titan wireless implantable hemodynamic monitor (Integrated Sensing Systems Inc)
90
Structured Review
Integrated Sensing Systems Inc
titan wireless implantable hemodynamic monitor
Titan Wireless Implantable Hemodynamic Monitor, supplied by Integrated Sensing Systems Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/titan+wireless+implantable+hemodynamic+monitor/titan+wireless+implantable+hemodynamic+monitor/10__1097_slash_mat__0000000000000777-5-127-133
Average 90 stars, based on 1 article reviews
Titan Wireless Implantable Hemodynamic Monitor, supplied by Integrated Sensing Systems Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/titan+wireless+implantable+hemodynamic+monitor/titan+wireless+implantable+hemodynamic+monitor/10__1097_slash_mat__0000000000000777-5-127-133
Average 90 stars, based on 1 article reviews
titan wireless implantable hemodynamic monitor - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Battery:Article Title: Applications of Implantable Hemodynamic Monitoring in the Setting of Durable Mechanical Circulatory Support Article Snippet: .. The use of wireless, battery-free, implantable, hemodynamic sensors to assess intravascular pressures has been demonstrated to improve clinical outcomes for patients with advanced heart failure and has now become incorporated into general clinical practice.1,2 Progress and advancement in this field has largely resulted from the investigational and clinical use of the CardioMEMS HF System (Abbott Laboratories, Abbott Park, IL).1,2 The CardioMEMS device is a wireless, battery-free, intravascular pressure sensor percutaneously positioned in the pulmonary artery (PA) to measure PA pressure (PAP) and is currently the only intravascular pressure sensor approved by the US Food and Drug Administration (FDA) for use in patients with heart failure.1,2 With the success of the CardioMEMS device, there has been significant development of a number of important competing technologies such as the |